Skip to main content
Sino Medical Sciences Technology Inc. logo

Sino Medical Sciences Technology Inc. — Investor Relations & Filings

Ticker · 688108 ISIN · CNE100003NY2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2026-04-07 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 688108

About Sino Medical Sciences Technology Inc.

https://www.sinomed.com/

Sino Medical Sciences Technology Inc. (SINOMED) specializes in the research, development, and manufacturing of high-end interventional medical devices. The company focuses on cardiovascular, neurovascular, and structural heart disease treatments. Its core product portfolio includes drug-eluting stents (DES) and balloon catheters, notably the BuMA and BuMA Supreme series. SINOMED utilizes proprietary technologies, such as the eG™ coating, to improve clinical outcomes and patient safety. The company maintains a strong commitment to clinical research and international expansion, aiming to provide innovative solutions for minimally invasive procedures.

Recent filings

Filing Released Lang Actions
赛诺医疗科学技术股份有限公司关于股份回购进展公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the progress of a share repurchase program by the company 赛诺医疗科学技术股份有限公司. It details the repurchase plan, the approval dates, the repurchase amount, and the current status of the repurchase (no shares repurchased yet). The document references regulatory compliance and provides specific dates and figures related to the share buyback. It does not contain financial statements or detailed financial analysis but is focused on the update of the share repurchase activity. According to the filing definitions, this fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document length is short and it is not a report publication announcement or a regulatory filing fallback. Therefore, the classification is POS with high confidence.
2026-04-07 Chinese
赛诺医疗科学技术股份有限公司2025年年度股东会会议资料
AGM Information Classification · 100% confidence The document is titled as "2025 年年度股东会 会议材料" which translates to "2025 Annual General Meeting (AGM) Meeting Materials". It contains detailed information about the AGM including meeting procedures, agenda, voting methods, reports to be discussed, and other meeting-related instructions. The content is focused on the materials shared for the AGM rather than the full annual report or financial statements themselves. The document length is substantial (15,000 characters), indicating it is not a brief announcement but the actual meeting materials. Therefore, it fits the category of AGM Information (AGM-R).
2026-04-07 Chinese
赛诺医疗科学技术股份有限公司关于第三届董事会独立董事专门会议第十二次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a specialized meeting of the independent directors of the company's board. It details the approval of proposals related to the issuance of H shares and listing on the Hong Kong Stock Exchange, as well as the use of proceeds and profit distribution plans. The document is a formal announcement of board meeting decisions rather than a full report or financial statement. It does not contain financial data or detailed analysis but rather the voting results and opinions of independent directors. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management.
2026-03-30 Chinese
赛诺医疗科学技术股份有限公司关于筹划发行H股股票并在香港联合交易所有限公司上市相关事项的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (1339 characters) regarding the company's plan to issue H shares and list on the Hong Kong Stock Exchange. It includes details about board resolutions, regulatory approvals needed, and the uncertainty of the listing process. There are no financial statements or detailed financial data presented. The document serves as a notification or update about a capital market activity (issuing shares and listing) but does not contain the actual issuance or detailed financing terms. Given the length and content, it is an announcement related to capital/financing activities rather than a full financing report or prospectus. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2026-03-30 Chinese
赛诺医疗科学技术股份有限公司独立董事提名人声明与承诺
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment by the nominator (the company's board) regarding the nomination of an independent director candidate for the company's board. It details the qualifications, legal compliance, independence criteria, and absence of adverse records for the nominee. There are no financial statements, earnings data, or report attachments. The content is related to board/management information, specifically about director nomination and qualifications. It does not fit into categories like Annual Report, Audit Report, or Earnings Release. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and focused on nomination, not a report or announcement of voting results or governance rules.
2026-03-30 Chinese
赛诺医疗科学技术股份有限公司股东会议事规则（H股发行并上市后适用）
Governance Information Classification · 95% confidence The document is titled as "赛诺医疗科学技术股份有限公司 股东会议事规则" which translates to "Sino Medical Science and Technology Co., Ltd. Shareholders Meeting Rules." The content extensively details the rules and procedures for convening, notifying, and conducting shareholders' meetings, including voting procedures, proposal submissions, meeting conduct, and legal compliance. It references relevant laws and stock exchange regulations, including the Hong Kong Listing Rules, and covers both annual and extraordinary general meetings. There is no financial data, earnings information, or audit content. The document is a governance-related rulebook for shareholder meetings rather than a report or announcement of a meeting or voting results. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2026-03-30 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.